Study on ADCT-602 for Treating Patients with Recurrent or Hard-to-Treat B-cell Acute Lymphoblastic Leukemia | Clinical Trial

Study on ADCT-602 for Treating Patients with Recurrent or Hard-to-Treat B-cell Acute Lymphoblastic Leukemia | Clinical Trial | Right2Hope